Robot-assisted radical prostatectomy in a patient with Zinner syndrome
Abstract
Introduction and importance: To our knowledge, this is the first reported case of Robot-Assisted Radical Prostatectomy (RARP) in a patient with Zinner syndrome, a rare congenital condition characterized by unilateral renal agenesis, seminal vesicle cysts, and ejaculatory duct obstruction.
Case presentation: A 64-year-old male with elevated PSA was diagnosed with low-risk prostate cancer. Preoperative imaging confirmed Zinner syndrome, posing unique anatomical challenges. The procedure was successfully performed using the Da Vinci robotic system, allowing precise removal of the prostate, non-functioning kidney, and dilated ureter from the standard port setting without changing the patient's position. The surgery was completed with minimal complications, and the patient recovered well.
Clinical discussion: The anatomical anomalies associated with Zinner syndrome complicate standard surgical approaches. Robotic-assisted techniques provide enhanced visualization and precision, facilitating safe and effective management of these cases.
Conclusion: This urological procedure can be safely and efficiently performed on patients with Zinner Syndrome and synchronous prostate cancer by urological surgeons with extensive experience in robotic surgery in high-volume centers.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.